.Transgene's therapeutic vaccine applicant TG4001 has actually failed a period 2 strong lump trial. ...
.Upstream Bio has swollen its IPO to $255 thousand as the company joins CAMP4 Therapeutics this morn...
.Sanofi has actually ceased a period 2 ordeal of Denali Therapeutics-partnered oditrasertib in vario...
.Turnstone Biologics is minimizing its head count through 60% and also shocking its own C-suite if y...
.In a year that has observed an authorization and a raft of readouts for metabolic dysfunction-assoc...
.Alaunos Rehabs is actually axing an arrangement along with Precigen, quiting licensing rights to a ...
.Capricor Rehabs is taking a triumph lap for their stage 2 Duchenne muscular dystrophy (DMD) trial. ...
.The FDA has put Kezar Life Sciences' lupus trial on hold after the biotech flagged 4 fatalities dur...
.A phase 3 test of Academic Rock's spinal muscular degeneration (SMA) prospect has struck its main e...
.RNA biotech CAMP4 Therapeutics has actually defined think about a $67 million IPO, along with infla...